Capricor Therapeutics Inc (CAPR) — Cash Flow Reinvestment Rate
Capricor Therapeutics Inc (CAPR) has a Cash Flow Reinvestment Rate of 0.76x as of March 2023, reinvesting $3.21 Million (capex $453.12K plus investments $-2.76 Million) from operating cash flow of $4.21 Million. Explore Capricor Therapeutics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Capricor Therapeutics Inc Cash Flow Reinvestment Rate (2014–2022)
Historical reinvestment intensity for Capricor Therapeutics Inc across 2 annual periods. Also explore CAPR total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Capricor Therapeutics Inc (2014–2022)
Year-by-year capital reinvestment analysis for Capricor Therapeutics Inc. For live market cap and broader valuation context, see Capricor Therapeutics Inc (CAPR) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 7.13x | $35.07 Million | $4.92 Million | $3.36 Million | ▲ +1230.6% |
| 2014 | 0.54x | $513.90K | $958.56K | $186.43K | — |